Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
Molecular FormulaC24H24N4O  | 
InChIKeyICDQFUFDAFKCAX-UHFFFAOYSA-N  | 
CAS Registry1533438-83-3  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Preclinical | United States   | 01 Aug 2015 | 





